NextCure, Inc. (NXTC) financial statements (2022 and earlier)

Company profile

Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200
BELTSVILLE, MD 20705
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments12,337283,448334,605
Cash and cash equivalents12,33732,77234,091
Short-term investments 250,676300,514
Restricted cash and investments391,7061,706
Other undisclosed current assets215,4412,8243,684
Total current assets:227,817287,978339,995
Noncurrent Assets
Property, plant and equipment13,99215,80912,090
Other noncurrent assets5772,8574,083
Total noncurrent assets:14,56918,66616,173
TOTAL ASSETS:242,386306,644356,168
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6,3918,5286,732
Accounts payable1,9423,9011,861
Accrued liabilities4,4494,6274,871
Debt 1,6671,667
Deferred rent credit217130215
Other undisclosed current liabilities  6,428
Total current liabilities:6,60810,32515,042
Noncurrent Liabilities
Long-term debt and lease obligation 1,8063,333
Long-term debt, excluding current maturities 1,8063,333
Liabilities, other than long-term debt2,392792359
Deferred rent credit2,392792359
Other undisclosed noncurrent liabilities  15,950
Total noncurrent liabilities:2,3922,59819,642
Total liabilities:9,00012,92334,684
Stockholders' equity
Stockholders' equity attributable to parent233,386293,721321,484
Common stock282827
Additional paid in capital421,047410,551402,529
Accumulated other comprehensive income (loss)(663)779(38)
Accumulated deficit(187,026)(117,637)(81,034)
Total stockholders' equity:233,386293,721321,484
TOTAL LIABILITIES AND EQUITY:242,386306,644356,168

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
Revenues 22,3786,347
Gross profit: 22,3786,347
Operating expenses(70,765)(63,603)(43,829)
Operating loss:(70,765)(41,225)(37,482)
Nonoperating income
(Other Nonoperating income)
1,3764,6223,745
Interest and debt expense (183)(209)
Loss before gain (loss) on sale of properties:(69,389)(36,786)(33,946)
Other undisclosed net income 183209
Net loss available to common stockholders, diluted:(69,389)(36,603)(33,737)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
Net loss:(69,389)(36,603)(33,737)
Comprehensive loss:(69,389)(36,603)(33,737)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(1,442)779(38)
Comprehensive loss, net of tax, attributable to parent:(70,831)(35,824)(33,775)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: